Drug Interactions between eplerenone and Lidotrans 5 Pak
This report displays the potential drug interactions for the following 2 drugs:
- eplerenone
- Lidotrans 5 Pak (lidocaine topical)
Interactions between your drugs
No interactions were found between eplerenone and Lidotrans 5 Pak. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
eplerenone
A total of 414 drugs are known to interact with eplerenone.
- Eplerenone is in the following drug classes: aldosterone receptor antagonists, potassium-sparing diuretics.
- Eplerenone is used to treat the following conditions:
Lidotrans 5 Pak
A total of 79 drugs are known to interact with Lidotrans 5 Pak.
- Lidotrans 5 pak is in the drug class topical anesthetics.
- Lidotrans 5 pak is used to treat the following conditions:
Drug and food interactions
eplerenone food
Applies to: eplerenone
Consumption of grapefruit, grapefruit juice, and supplements that contain grapefruit should be avoided during treatment with eplerenone as they may increase the blood levels and effects of eplerenone. High blood levels of eplerenone can increase the risk of side effects including hyperkalemia (high blood potassium), which in severe cases can lead to kidney failure, muscle paralysis, irregular heart rhythm, and cardiac arrest. You may be more likely to develop hyperkalemia during treatment with eplerenone if you are elderly, dehydrated, or have kidney disease, diabetes, or advanced heart failure. You should seek medical attention if you experience nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat, as these may be symptoms of hyperkalemia. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.